Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy

This single-group supportive care study provides an Apollo wearable (transcutaneous vibratory stimulation, 10–200 Hz) to participants who completed MAPS MDMA‑assisted psychotherapy to assess effects on PTSD symptoms, mood, anxiety and emotion regulation.

Participants receive the device and app, are instructed to use it daily (≥30 minutes morning and evening), and complete monthly online questionnaires for two years. The study is independent of MAPS.